The FDA approved first-time generics for Xeljanz, two COPD medications, and more.
The FDA approved first-time generics for Xeljanz, two COPD medications, and more.
New data from a safety trial creates concern surrounding the rheumatoid arthritis drug.
Migraine, arthritis, and insomnia drug approvals, and a gabapentinoids safety warning.
A biosimilar to Humira is approved, the FDA Fast Tracks a PTSD drug, and more.
